We use cookies to give you the best possible experience with eirhub.eu. Some are essential for this site to function; others help us understand how you use the site, so we can improve it. We may also use cookies for targeting purposes. Click “Accept all cookies” to proceed as specified, or click “Manage my preferences” to choose the types of cookies you will accept. Cookie policy
Privacy Preference Center
Eirhub and our trusted partners use cookies and similar technologies to access and use your data for the purposes listed below. Please provide your consent for cookie usage on this website. Enable one or more of the cookie types listed below, and then save your preferences. Cookie policy
Manage Consent Preferences
Performance Cookies
on
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Active (Inactive)
Functional Cookies
off
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly. Active (Inactive)
Targeting Cookies
off
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising. Active (Inactive)
Strictly Necessary Cookies
on
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information. Always Active
focused

Early Access Programs

Comprehensive market access and regulatory support in pharmaceutical early access programs. Unlock strategic insights for effective navigation of Ukraine's regulatory landscape.

Supporting Early Access Programs in Ukraine, CEE, and beyond

Target industries: Pharmaceuticals/ Biopharmaceuticals

Case studies:


The Eirhub team offers various support to pharma and biopharma companies in Ukraine, CEE, Central Asia, and the South Caucasian countries, including:
  • COMPREHENSIVE REGULATORY ANALYSIS—A thorough analysis of the regulatory framework governing early and extended access programs. This includes reviewing existing regulations, guidelines, and requirements to ensure compliance.
  • STAKEHOLDER MAPPING—Identifying and mapping all relevant stakeholders involved in early access programs, including regulatory authorities, ethics committees, patient advocacy groups, healthcare providers, and pharmaceutical companies.
  • COMPETITIVE TREATMENT OPTIONS ANALYSIS—A detailed analysis of registered competitive treatment options in Ukraine. This includes assessing the efficacy, safety, and pricing of these treatments.
  • ANALYTICAL REPORT ON TARGET INDICATIONS—An analytical report focused on the target patient populations for specific indications. Such a report would include information on disease prevalence, demographics, and unmet medical needs.
  • PRICING ANALYSIS—Analyzing the price parameters of available treatment methods in Ukraine is essential to understanding the economic aspects of early access programs. This information can be valuable for possible future pricing and reimbursement strategies.
  • IDENTIFYING TARGET MEDICAL INFRASTRUCTURE—Identifying healthcare institutions and treating physicians willing to participate in early access programs for specific indications. Assessing their readiness and willingness to participate in early access programs.
  • RECOMMENDATIONS and COMMUNICATION PLAN—Formulating recommendations for decision-makers and developing a comprehensive communication plan. This plan will address the needs and expectations of each stakeholder group, including HCPs, patient advocacy groups, payors, authorities, and distributors.
Download
our Brochure